Minerva Neurosciences Inc (NERV) is not a strong buy at this moment for a beginner investor with a long-term strategy. The financial performance is weak, with declining net income and EPS, and there are no significant positive catalysts or trading signals to justify immediate investment. The technical analysis shows a neutral to slightly bearish trend, and no significant news or influential trading activity has been reported.

Technical Analysis

The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 63.039, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 6.221, with key resistance at 6.615 and support at 5.828. However, the overall technical indicators do not suggest a strong buy signal.

Positive Catalysts

NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress.

Neutral/Negative Catalysts

No significant trading trends or positive sentiment from hedge funds or insiders.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -2,743,954 (-112.19% YoY), and EPS also declined to -0.36 (-112.12% YoY). Gross margin remained at 0 with no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

2 Analyst Rating

Wall Street analysts forecast NERV stock price to fall

0 Buy

2 Hold

0 Sell

Hold

Current: 6.860

Low

Averages

4.5

High

Current: 6.860

Low

Averages

4.5

High

H.C. Wainwright

Neutral

downgrade

$5 -> $4

AI Analysis

2025-11-06

Reason